Skip to main content

Mckesson Medical-Surgical Inc. Corporate Office

5 ongoing recalls and 152 historical records

Based on the official records currently available to Public Health Trace, 5 recalls naming Mckesson Medical-Surgical Inc. Corporate Office are currently shown as ongoing. The other 152 records below are historical.

Public Health Trace has 157 recalls naming Mckesson Medical-Surgical Inc. Corporate Office as the recalling firm, republished from official FDA and USDA sources.

Recall records - 157 total

Recalls by year

A bar chart of the number of recalls naming this company by year.

Recalls by year
YearRecalls
202290
20245
20255
Download CSV

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

EPI-PEN 2-PAK (epinephrine injection, USP), Single-Dose Auto-Injectors 0.3 mg, Rx only, Manufactured for: Mylan Specialty LP., NDC 49502-500-02

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

Some FDA recall records on this page come from FDA's Enforcement Report database. Not every Enforcement Report record has a separate FDA.gov recall-announcement page.

This page lists recalls that name Mckesson Medical-Surgical Inc. Corporate Office as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.